Neurocrine Biosciences Inc (NASDAQ:NBIX)

Add to Watch List

Set Alert

Tuesday’s trading has closed, but NBIX is being traded in the after-hours session. After-Hours quote »

12.06 Data as of 4:00pm ET	+0.05 / +0.42% Today’s Change	6.25 Today\|\|\|52-Week Range 12.85	+61.23% Year-to-Date

12.06

Data as of 4:00pm ET

+0.05 / +0.42%

Today’s Change

6.25

Today|||52-Week Range

12.85

+61.23%

Year-to-Date

SECTOR

Health Technology

INDUSTRY

Biotechnology

MARKET CAP

$801.5M

Company Description

Neurocrine Biosciences, Inc. operates as a product based biopharmaceutical company, which discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Its product candidates address endometriosis, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Contact Information

Neurocrine Biosciences, Inc.

12780 El Camino Real

San Diego California 92130

P:(858) 617-7600

Investor Relations:
(858) 617-7600

www.neurocrine.com

Employees

Shareholders

Mutual fund holders	49.16%
Other institutional	37.84%
Individual stakeholders	11.03%

Top Executives

Kevin C. Gorman, PhD, MBA	President, Chief Executive Officer & Director
Bill Wilson	Vice President-Information Technology & Operations
Timothy P. Coughlin, CPA	Chief Financial Officer
Haig P. Bozigian, PhD	Chief Development Officer
Dimitri E. Grigoriadis, PhD	Chief Research Officer

To view my watchlist

Not a member yet?

jobs by

Search for jobs

Search All Jobs from Across the Web

About CNNMoney
Content
Magazines
Site Tools
Stay Connected
- My Account
- Mobile Site & Apps
- Facebook
- Twitter
- LinkedIn
- YouTube
- RSS Feeds
- Newsletters
- Tumblr
- Google+

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2013 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones Indexes^SM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones Indexes^SM © 2013 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2013. All rights reserved. Most stock quote data provided by BATS.